Testing effectiveness (Phase 2)Ended earlyNCT01357655What this trial is testingPhase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)Who this might be right forLeukemia Bristol-Myers Squibb 70
Early research (Phase 1)Study completedNCT01576666What this trial is testingPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsWho this might be right forDose EscalationSafetyPreliminary Efficacy+9 more Novartis Pharmaceuticals 120
Not applicableStudy completedNCT01529450What this trial is testingPilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened InhibitorsWho this might be right forBasal Cell Carcinoma Anne Chang 11